Envoy Medical, Inc. is focused on developing innovative medical device solutions to enhance patient care, particularly in the field of hearing health. The company is known for its advancements in implantable technologies designed to treat hearing loss, offering alternatives to traditional hearing aids. By integrating cutting-edge technology with a commitment to improving quality of life for individuals with hearing impairments, Envoy Medical aims to empower patients through better auditory experiences and satisfaction. Their products seek to address a significant unmet need in the healthcare market, emphasizing the importance of accessibility and effectiveness in medical treatments.
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.
Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering. BioVie shares dipped 41.8% to $1.10 in pre-market trading Here are some other stocks moving in pre-market trading.
Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and
